Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
An intrauterine system (IUS) containing a candidate progesterone agonist - likely etonogestrel, the synthetic progestin that is in Implanon/Nexplanon. Dosage under study.
July 21, 2016
Active Pharmaceutical Ingredient (API):
Potential Multi-Purpose Technology (MPT):
38mg, 61mg or 72mg
Phase II studies were completed in July 2011 to test different quantities of etonogestrel (38mg, 61mg, 72mg) and different thicknesses of the reservoir’s membrane (350 μm, 140 μm, and 50 μm), respectively. This work was done under authority of the European Medicines Agency.
Clinical Trials Report
Download Product Report